Article Information
- Received July 14, 2014
- Revision received March 15, 2015
- Accepted March 17, 2015
- First published May 27, 2015.
- Version of record published May 27, 2015.
Author Information
- Elske H. P. Franssen1,*,
- Rong-Rong Zhao1,*,
- Hiroaki Koseki1,
- Venkateswarlu Kanamarlapudi2,
- Casper C. Hoogenraad3,
- Richard Eva1, and
- James W. Fawcett1
- 1Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 OPY, United Kingdom,
- 2Institute of Life Science 1, College of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom; and
- 3Cell Biology, Faculty of Science, Utrecht University, 3584 CH Utrecht, The Netherlands
Author contributions
Author contributions: E.H.P.F., R.-R.Z., R.E., and J.W.F. designed research; E.H.P.F., R.-R.Z., H.K., and R.E. performed research; V.K. and C.H. contributed unpublished reagents/analytic tools; E.H.P.F., R.-R.Z., and R.E. analyzed data; E.H.P.F., R.-R.Z., R.E., and J.W.F. wrote the paper.
↵*E.H.P.F. and R.-R.Z. contributed equally to this work.
Disclosures
- Received July 14, 2014.
- Revision received March 15, 2015.
- Accepted March 17, 2015.
This work was supported by the Medical Research Council, the Christopher and Dana Reeve Foundation, European Union Framework 7 Project Plasticise, the European Research Council, the John and Lucille van Geest Foundation, and the National Institute for Health Research Cambridge Biomedical Research Centre. We thank Matthew N. Rasband for kindly providing the adenoviruses for AnkG silencing experiment, Juan Bonifacino for AP-1 constructs, and Menghon Cheah for assistance.
J.W.F. is a paid consultant for Acorda Therapeutics and Vertex Pharmaceuticals. The remaining authors declare no competing financial interests.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
- Correspondence should be addressed to either James Fawcett or Richard Eva, John van Geest Centre for Brain Repair, Robinson Way, Cambridge CB2 0PY, UK. jf108{at}cam.ac.uk or re263{at}cam.ac.uk
Online Impact